Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib can help about 14,000 people with severe hair loss.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Citrate is a safer alternative to heparin for preventing blood clots in hemodialysis.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

An 8-year-old boy developed a rare condition after a liver transplant, which improved after changing his medication.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

A circulating inhibitor caused insulin resistance, but clomiphene improved symptoms.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.